Vectura Group CFO joins Elementis board

THE CHIEF FINANCIAL OFFICER of Vectura Group has joined FTSE 250 specialty chemicals company Elementis as a non-executive director with effect from 1 June 2013.

Anne Hyland has been CFO of Vectura since 2002, a product development company in the pharmaceutical sector which develops therapeutic products principally for the treatment of respiratory diseases.

Previously, she held a number of senior finance positions including director of corporate finance at then FTSE 100 Celltech Group, Medeva and KPMG. She is a chartered accountant and a corporate tax adviser.

Bob Beeston, chairman of Elementis, said: “Anne brings an impressive track record with her to the board both as a proven and commercially astute CFO and corporate finance professional and from having extensive international experience in the areas of product development and commercialising technology. She will be a welcome addition to our board and I am delighted that she has accepted the position and look forward to working with her”.

Elementis shares rose 8.5p to 255.7p in morning trading on the London Stock Exchange.

For more information visit the Share Price Centre

Related reading